USE OF PRODUCTS IN CAPITAL PUNISHMENT

  Hikma aims to improve lives by providing patients with access to high quality, affordable medicines.  Our medicines are used thousands of times a day around the world to treat illness and save lives.

  We object in the strongest possible terms to the use of any of our Products for the purpose of Capital Punishment. Not only is it contrary to the intended label use(s) for the Products, but it is also inconsistent with our values and mission of improving lives by providing quality, affordable healthcare to patients.

  While none of our Products should ever be used for the purpose of Capital Punishment, in the table below, we have identified certain products that carry heightened risk of misuse for lethal injection protocols.  Accordingly, to prevent these Products from being used for the purpose of Capital Punishment, we will not accept orders for these products directly from any Departments of Correction or correctional facilities in the United States, unless accompanied by an original, raised seal copy of an affidavit signed by the state Attorney General (or Governor), certifying under penalty of perjury that the product(s) will not be used for Capital Punishment.  Further, we will only sell these same Products to pre-selected commercial customers who agree that they will not then sell or provide them to Departments of Corrections/correctional facilities, or to secondary distributors or retail pharmacies.

  We vigorously monitor the distribution of these Products and support industry serialization efforts that will help enhance these controls while continuing to promote our values and mission. 

  Further, transparency is one of our core values, and as such we object to attempts by any entity, person or state to obscure or hide the source of Products for lethal injection. It is imperative that we are not impeded from protecting patient health and the integrity of our Products and our supply chain. 

Name / Description 

fentaNYL Citrate 1,000 mcg per 100 mL (10 mcg/mL) in 0.9% Sodium Chloride Injection

fentaNYL Citrate 2,500 mcg per 250 mL (10 mcg/mL) in 0.9% Sodium Chloride Injection

fentaNYL Citrate 100 mcg per 2 mL (50 mcg/mL) Injection
fentaNYL Citrate 250 mcg per 5 mL (50 mcg/mL) Injection

fentaNYL Citrate 2 mcg/mL (200 mcg per 100 mL) bupivacaine HCl 0.125% (125 mg per 100 mL) in 0.9% Sodium Chloride Injection

fentaNYL Citrate 2 mcg/mL (500 mcg per 250 mL) bupivacaine HCl 0.125% (312.5 mg per 250 mL) in 0.9% Sodium Chloride Injection

fentaNYL Citrate 4 mcg/mL (1000 mcg per 250 mL) bupivacaine HCl 0.125% (312.5 mg per 250 mL) in 0.9% Sodium Chloride Injection
ketamine HCl 50 mg per 5 mL (10 mg/mL) in 0.9% Sodium Chloride Injection
ketamine HCl 50 mg per mL Injection
ketamine HCl 100 mg per 2 mL (50 mg/mL) Injection

rocuronium Bromide 50 mg per 5 mL (10 mg/mL) Injection

rocuronium Bromide 100 mg per 10 mL (10 mg/mL) Injection

Last Updated on August 22, 2022